Share

Gender-Affirming Care: Bridging the Gap

ENDO_2022_4C As transgender medical care becomes unfairly politicized, presentations such as ENDO 2022’s Meet the Professor session “Beginner’s Guide to Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Adults” are more essential than ever. Attendees will be shown a variety of best practices in providing affirming care to transgender and gender diverse adults.   On the...
Share

Does Thyroid Hormone Replacement Undertreatment Worsen Hospital Outcomes?

Study finds undertreatment can lead to longer stay and higher readmission rates. Undertreatment with thyroid hormone replacement can put patients with hypothyroidism at risk for worse hospital outcomes, including longer length of stay and higher rates of readmission, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism. Hypothyroidism, or...
Share

NEW ENDO 2022 Experiences You Can’t Miss!

april 2022 cover Our first hybrid ENDO 2022 includes enhanced experiences for attendees from in-person networking events to new opportunities for endocrine scientists that you surely will not want to miss. Our team is working hard to make sure this ENDO is the best one yet and is dedicated to revamping the experience to include in-person features to...
Share

Data Presented at ENDO 2021 Shows Promise for Treating Cushing’s Syndrome

A poster presented at ENDO 2021 appears to show promise for a new treatment aimed at patients with Cushing’s syndrome. The poster, presented by Strongbridge Biopharma, plc, a global commercial-stage biopharmaceutical company, announced that detailed results from the previously reported Phase 3 LOGICS study of RECORLEV® (levoketoconazole) in patients with endogenous Cushing’s syndrome were presented...
Share

Plenary Pioneers, Part 2: On the Right Track: How the Many Paths of GPCRs Could Lead to Treatment Breakthroughs

Twitter_Post_ENDO_2021_Virtual At ENDO 2021, the first time the Endocrine Society’s annual conference has gone all-virtual, a live Presidential Plenary on March 20 will feature a pair of presentations on the latest developments in basic tissue engineering. Nobel Prize winner Brian Kobilka, MD, talks to Endocrine News about his session, “Structural Insights into G Protein-Coupled Receptor Activation:...